• Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$95.0k

Seed
*

$17.4m

Series A
*

N/A

Series B
Total Funding€15.9m

Recent News about Amalgam Rx

Edit
More about Amalgam Rxinfo icon
Edit

Amalgam Rx operates in the digital health sector, focusing on developing and deploying regulated software and algorithms that assist patients and healthcare providers in making informed decisions. The company serves a diverse clientele, including patients, healthcare providers, and clinical trial recruiters, across multiple continents. Amalgam Rx leverages its robust Quality Management System (QMS) and extensive experience with the FDA and other regulatory bodies to ensure compliance and efficacy of its Software as a Medical Device (SaMD) solutions. The business model revolves around creating and scaling digital health solutions that are cleared for use by regulatory authorities, thereby generating revenue through direct sales and partnerships with healthcare organizations and insurers. Amalgam Rx's mission is to empower better healthcare decisions through innovative digital therapeutics and support programs, ultimately transforming care delivery.

Keywords: digital health, regulated software, algorithms, patient support, provider support, clinical decision, SaMD, FDA compliance, global deployment, digital therapeutics.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Amalgam Rx

Edit
Avhana
ACQUISITION by Amalgam Rx Jan 2021